EUVIMEDEUVIMED entdecken
Crossref

Life and death with Multiple Sclerosis: 20 years reappraisal of Verona prevalence cohort.

Riccardo Orlandi, Fabio Bonomi, Francesca Calabria, Alberto Gajofatto

Neuroepidemiology · 2025

DOI: 10.1159/000544845 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroepidemiology, 2025. Verfasst von Riccardo Orlandi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy. Hauptthemen laut MEDLINE: Multiple Sclerosis.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Multiple sclerosis (MS) is a debilitating condition which results in increased mortality rates in people with MS compared to general population (GP). Recent data suggest a potential rise in survival over the past 20 years.

Objectives

Evaluate the 20-year (2001-2021) survival rate and assess clinical factors associated with mortality among people with MS in Verona, Italy.

Methods

We evaluated all the prevalent cases of MS residing in Verona, Italy at 31/12/2001. We retrospectively investigated the survival state of each patient at 31/12/2021 through the consultation of medical records to assess if patients were still on follow-up; for those with no records, we surveyed the death certificates from Verona municipality to verify death notification and date. The groups of survived and deceased patients were compared by sex, variables related to disease onset (age, clinical phenotype, number and type of functional systems involved, oligoclonal bands) or collected at prevalence date (clinical phenotype, disease duration, exposure to disease-modifying treatment, EDSS, annual relapse rate).

Results

Of the 273 prevalent MS cases (189 females) as of 31/12/2001, 73 patients (48 females) had died by 31/12/2021. Mean life expectancy deviation of deceased MS patients was – 17.0±12.4 years compared to the GP. Deceased patients had a higher mean age at onset (36.4±12.5 vs 30.5±10.0 years; p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisHumansFemaleMaleItalyAdultPrevalenceMiddle AgedRetrospective StudiesCohort StudiesSurvival Rate

Stichwörter der Autor:innen

Clinical factorsEpidemiologyItalyMortalityMultiple sclerosisVerona

Autor:innen und Institutionen

  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy.
  • Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy, fabio.bonomi@univr.it.
  • Neurology Unit, Verona University Hospital, Verona, Italy.

Zitieren

APA

Orlandi, R., Bonomi, F., Calabria, F., & Gajofatto, A. (2025). Life and death with Multiple Sclerosis: 20 years reappraisal of Verona prevalence cohort. Neuroepidemiology. https://doi.org/10.1159/000544845

Vancouver

Orlandi R, Bonomi F, Calabria F, Gajofatto A. Life and death with Multiple Sclerosis: 20 years reappraisal of Verona prevalence cohort. Neuroepidemiology. 2025. doi:10.1159/000544845

BibTeX
@article{Orlandi2025,
  author = {Orlandi, Riccardo and Bonomi, Fabio and Calabria, Francesca and Gajofatto, Alberto},
  title = {Life and death with Multiple Sclerosis: 20 years reappraisal of Verona prevalence cohort},
  journal = {Neuroepidemiology},
  year = {2025},
  doi = {10.1159/000544845}
}
Kostenlos starten →